Johnson & Johnson wins reversal of $1.2 billion Arkansas Risperdal judgment

Johnson & Johnson on Thursday won the reversal by the Arkansas Supreme Court of a roughly $1.2 billion judgment in a lawsuit accusing the company of improperly marketing the anti-psychotic drug Risperdal.

Read the source article at

About the Author

Leave a Reply